Citation Impact
Citing Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
2010 Standout
Induced-fit tightens pleuromutilins binding to ribosomes and remote interactions enable their selectivity
2007 StandoutNobel
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Diagnosis and Management of Complicated Intra-abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America
2009 Standout
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
2017 Standout
Bacteremia due to multiresistant gram-negative bacilli in neutropenic cancer patients: a case-controlled study
1999
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies
2006
Mutations in 23S rRNA Account for Intrinsic Resistance to Macrolides in Mycoplasma hominis and Mycoplasma fermentans and for Acquired Resistance to Macrolides in M. hominis
2002
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
Risk Factors and Predictors of Outcome in Patients with Cancer and Breakthrough Candidemia
2001
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
Fluconazole prophylaxis in critically ill surgical patients: A meta-analysis*
2005
Viridans Group Streptococcal Infections Among Children With Cancer and the Importance of Emerging Antibiotic Resistance
2006
Candidemia in a Tertiary Care Cancer Center
2003
Comparative impact of hospital-acquired infections on medical costs, length of hospital stay and outcome between community hospitals and medical centres
2005
Current Trends in the Epidemiology of Nosocomial Bloodstream Infections in Patients with Hematological Malignancies and Solid Neoplasms in Hospitals in the United States
2003
Multi-laboratory comparison of eight commercially availableHelicobacter pylori serology kits
1995
An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii
2007 Standout
In Vivo Pathogenicity of Eight Medically Relevant Candida Species in an Animal Model
2002
Infective Endocarditis Due to Penicillin-Resistant Viridans Group Streptococci
2007
Candida lusitaniae: A Cause of Breakthrough Fungemia in Cancer Patients
2001
High-level telithromycin resistance in laboratory-generated mutants of Streptococcus pneumoniae
2003
Antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and group A β-haemolytic streptococci in 2002–2003
2005
Epidemiological Investigation of Fluoroquinolone Resistance in Infections Due to Extended‐Spectrum β‐Lactamase–ProducingEscherichia coliandKlebsiella pneumoniae
2001
Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections
2003
1997 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever
1997
Pseudomonas infections in the thermally injured patient
2003
Glucocorticoids and invasive fungal infections
2003
From peptide‐bond formation to cotranslational folding: dynamic, regulatory and evolutionary aspects
2004 StandoutNobel
Correlating ribosome function with high-resolution structures
2008 StandoutNobel
Utility of real-time antifungal susceptibility testing for fluconazole in the treatment of candidemia
2004
Gut microbiota modulation of chemotherapy efficacy and toxicity
2017 Standout
Echinocandin antifungal drugs
2003 Standout
The central nervous system and infection by Candida species
2000
Infections due to emerging and uncommon medically important fungal pathogens
2004
Antifungal prophylaxis for severely neutropenic chemotherapy recipients
2002
Effects of the enteral administration of Bifidobacterium breve on patients undergoing chemotherapy for pediatric malignancies
2009
Chronic disseminated candidiasis in patients with acute leukemia: emphasis on diagnostic definition and treatment
2004
Ribosomal crystallography: a flexible nucleotide anchoring tRNA translocation, facilitates peptide‐bond formation, chirality discrimination and antibiotics synergism
2004 StandoutNobel
Fluoroquinolone-Resistant Pseudomonas aeruginosa: Assessment of Risk Factors and Clinical Impact
2006
A crevice adjoining the ribosome tunnel: Hints for cotranslational folding
2005 StandoutNobel
Epidemiology, treatment and outcome of candidemia: a five‐year review at three Canadian hospitals
2002
Trends in species causing fungaemia in a tertiary care medical centre over 12 years
2001
A Dominant Complement Fixation Pathway for Pneumococcal Polysaccharides Initiated by SIGN-R1 Interacting with C1q
2006 StandoutNobel
Two Cases of Fungemia due to Candida lusitaniae and a Literature Review
2002
Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences
2002
Candidemia in Allogeneic Blood and Marrow Transplant Recipients: Evolution of Risk Factors after the Adoption of Prophylactic Fluconazole
2000
Possible Role of Catheters in Saccharomyces boulardii Fungemia
2000
Successful ceftriaxone therapy of endocarditis due to penicillin non-susceptible viridans streptococci
2006
Immunity to fungal infections
2011 Standout
The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling
2007 Standout
Biological counterstrike: antibiotic resistance mechanisms of Gram-positive cocci
2005
Candida lusitaniaeInfections in the Era of Fluconazole Availability
2003
Timing of susceptibility-based antifungal drug administration in patients with Candida bloodstream infection: correlation with outcomes
2011
-D-Glucan as a Diagnostic Adjunct for Invasive Fungal Infections: Validation, Cutoff Development, and Performance in Patients with Acute Myelogenous Leukemia and Myelodysplastic Syndrome
2004
In vivo activity of micafungin in a persistently neutropenic murine model of disseminated infection caused by Candida tropicalis
2002
Global Distribution and Outcomes for Candida Species Causing Invasive Candidiasis: Results from an International Randomized Double-Blind Study of Caspofungin Versus Amphotericin B for the Treatment of Invasive Candidiasis
2003
Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999
2004
Epidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant Recipients
2002 Standout
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
2007 Standout
Emerging and less common fungal pathogens
2002
Antimicrobial Susceptibility Patterns among Viridans Group Streptococcal Isolates from Infective Endocarditis Patients from 1971 to 1986 and 1994 to 2002
2004
Resistance to Macrolides and Related Antibiotics in Streptococcus pneumoniae
2002
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Treatment of drug-resistant pneumococcal pneumonia
2002
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
Comprehensive genetic selection revealed essential bases in the peptidyl-transferase center
2006 StandoutNobel
23S rRNA base pair 2057–2611 determines ketolide susceptibility and fitness cost of the macrolide resistance mutation 2058A→G
2005 StandoutNobel
23S rRNA 2058A→G Alteration Mediates Ketolide Resistance in Combination with Deletion in L22
2006 StandoutNobel
Fusarium, a Significant Emerging Pathogen in Patients With Hematologic Malignancy: Ten Years' Experience at a Cancer Center and Implications for Management
1997
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
Carbapenemases: the Versatile β-Lactamases
2007 Standout
Practice Guidelines for the Diagnosis and Management of Skin and Soft-Tissue Infections
2005
Antifungal Susceptibility ofCandidaBiofilms: Unique Efficacy of Amphotericin B Lipid Formulations and Echinocandins
2002
TLR4 and Toll-IL-1 Receptor Domain-Containing Adapter-Inducing IFN-β, but Not MyD88, RegulateEscherichia coli-Induced Dendritic Cell Maturation and Apoptosis In Vivo
2005
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy
2012
Extended-Spectrum β-Lactamases: a Clinical Update
2005 Standout
Invasive Candidiasis
2015 Standout
Safety and Tolerability of Fluconazole in Children
1999
2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer
2002 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Activity of Retapamulin against Streptococcus pyogenes and Staphylococcus aureus Evaluated by Agar Dilution, Microdilution, E-Test, and Disk Diffusion Methodologies
2006
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Structural basis for cross-resistance to ribosomal PTC antibiotics
2008 StandoutNobel
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Burn Wound Infections
2006 Standout
Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
2012 Standout
Reappraisal With Meta-Analysis of the Addition of Gram-Positive Prophylaxis to Fluoroquinolone in Neutropenic Patients
2003
2015 ESC Guidelines for the management of infective endocarditis
2015 Standout
Antifungal Prophylaxis in Cancer Patients After Chemotherapy or Hematopoietic Stem-Cell Transplantation: Systematic Review and Meta-Analysis
2007
Geographic Variation in the Susceptibilities of Invasive Isolates of Candida glabrata to Seven Systemically Active Antifungal Agents: a Global Assessment from the ARTEMIS Antifungal Surveillance Program Conducted in 2001 and 2002
2004
ANTIBIOTICS TARGETING RIBOSOMES: Resistance, Selectivity, Synergism, and Cellular Regulation
2005 StandoutNobel
Guidelines for Treatment of Candidiasis
2004 Standout
A Broader View: Microbial Enzymes and Their Relevance in Industries, Medicine, and Beyond
2013
Meta-Analysis: Antibiotic Prophylaxis Reduces Mortality in Neutropenic Patients
2005
Update of Practice Guidelines for the Management of Community-Acquired Pneumonia in Immunocompetent Adults
2003
Structure of trigger factor binding domain in biologically homologous complex with eubacterial ribosome reveals its chaperone action
2005 StandoutNobel
Antibiotic Resistance Genes as Emerging Contaminants: Studies in Northern Colorado
2006 Standout
Comparison of Biofilms Formed byCandidaalbicansandCandidaparapsilosison Bioprosthetic Surfaces
2002
Multiple Antibiotic Resistance in Stenotrophomonas maltophilia : Involvement of a Multidrug Efflux System
2000
Works of J. Trupl being referenced
Toxinogenicity and markers of pathogenicity ofPseudomonas aeruginosa strains isolated from patients with tumor diseases
2002
Fungal Pathogens in Etiology of Septic Shock in Neutropenic Patients with Cancer (Short Communication)
1993
Invasive mold infections in cancer patients: 5 years' experience withAspergillus, Mucor, Fusarium andAcremonium infections
1996
Hematogenous trichosporonosis in cancer patients: report of 12 cases including 5 during prophylaxis with itraconazol
1999
Prevention of febrile neutropenia in cancer patients by probiotic strain Enterococcus faecium M-74. Phase II study
2005
Bacteremia Due to Multiresistant Gram-Negative Bacilli in Neutropenic Cancer Patients: A Case Controlled Study
1998
Fungemia in Cancer Patients Undergoing Chemotherapy Versus Surgery: Risk Factors, Etiology and Outcome
1997
Bacteremia due to methicillin-resistant staphylococci occurs more frequently in neutropenic patients who received antimicrobial prophylaxis and is associated with higher mortality in comparison to methicillin-sensitive bacteriemia
1998
Breakthrough Fungemia Appearing during Empiric Therapy with Amphotericin B
1997
Antifungal susceptibility of 262 bloodstream yeast isolates from a mixed cancer and non-cancer patient population: is there a correlation between in-vitro resistance to fluconazole and the outcome of fungemia?
2000
Nosocomial candidaemias due to species other than Candida albicans in cancer patients
1999
Activity of telithromycin and seven other agents against 1034 pediatric Streptococcus pneumoniae isolates from ten central and eastern European centers
2003
Bacteremias caused by Escherichia coli in cancer patients — analysis of 65 episodes
2002
Fluconazole in Children: First Experience with Prophylaxis in Chemotherapy-Induced Neutropenia in Pediatric Patients with Cancer
1993
<i>Candida</i><i>glabrata</i>, <i>Candida</i><i>krusei</i>, Non-albicans <i>Candida</i> spp., and Other Fungal Organisms in a Sixty-Bed National Cancer Center in 1989-1993: No Association with the Use of Fluconazole
1995
Activity of telithromycin compared with seven other agents against 1039 Streptococcus pyogenes pediatric isolates from ten centers in central and eastern Europe
2003
Netilmicin plus Ceftriaxone versus Amikacin plus Ceftriaxone in the Treatment of Infections in Granulocytopenic Patients
1992
Eight-Year Surveillance of Non-Albicans Candida spp . in an Oncology Department Prior to and After Fluconazole Had Been Introduced into Antifungal Prophylaxis
1997
Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome
1998
Viridans Streptococcal Bacteraemia Due to Penicillin-Resistant and Penicillin-Sensitive Streptococci: Analysis of Risk Factors and Outcome in 60 Patients from a Single Cancer Centre Before and After Penicillin is Used for Prophylaxis
1997
Fungaemia due to Fusarium spp. in cancer patients
1997
NosocomialCandida kruseiFungemia in Cancer Patients: Report of 10 Cases and Review
1999
Teicoplanin plus Pefloxacine versus Teicoplanin plus Netilmicin in Empiric Therapy of Febrile Patients with Cancer and Neutropenia
1994
Transduction of antibiotic resistance including imipenem resistance by wild type phages from nosocomial strains of Pseudomonas aeruginosa.
1997
Prevention of febrile neutropenia in cancer patients by probiotic strain Enterococcus faecium M-74. Pilot study phase I.
2005
[IgG antibodies to Gastrospirillum hominis and Helicobacter pylori].
1993
Susceptibilities to Telithromycin and Six Other Agents and Prevalence of Macrolide Resistance Due to L4 Ribosomal Protein Mutation among 992 Pneumococci from 10 Central and Eastern European Countries
2002
Bacteremia Due to CiprofLoxacin-Resistant Pseudomonas Aeruginosain Cancer Patients: Risk Factors for Resistance and Outcome of 25 Episodes. A Case-Control Study
1999
Susceptibility to Telithromycin in 1,011 Streptococcus pyogenes Isolates from 10 Central and Eastern European Countries
2002